OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema
Pierre‐Henry Gabrielle, Hemal Mehta, Daniel Barthelmes, et al.
Progress in Retinal and Eye Research (2023) Vol. 97, pp. 101219-101219
Open Access | Times Cited: 7
Pierre‐Henry Gabrielle, Hemal Mehta, Daniel Barthelmes, et al.
Progress in Retinal and Eye Research (2023) Vol. 97, pp. 101219-101219
Open Access | Times Cited: 7
Showing 7 citing articles:
Assessing variation in US payer coverage of anti–vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edema
James D. Chambers, Molly T. Beinfeld, Terry Richardson, et al.
Journal of Managed Care & Specialty Pharmacy (2025), pp. 1-10
Closed Access
James D. Chambers, Molly T. Beinfeld, Terry Richardson, et al.
Journal of Managed Care & Specialty Pharmacy (2025), pp. 1-10
Closed Access
Real-life evaluation of the home vision monitoring application Odysight® in primary and secondary prevention of exudative maculopathies
Auberie Bonjean, Mathieu Lehmann, Laura Moyal, et al.
JFO Open Ophthalmology (2025), pp. 100166-100166
Open Access
Auberie Bonjean, Mathieu Lehmann, Laura Moyal, et al.
JFO Open Ophthalmology (2025), pp. 100166-100166
Open Access
Recommandations pour l’utilisation raisonnée des nouvelles molécules anti-VEGF
Catherine Creuzot‐Garcher, Bahram Bodaghi, Salomon Y. Cohen, et al.
Journal Français d Ophtalmologie (2025) Vol. 48, Iss. 6, pp. 104536-104536
Closed Access
Catherine Creuzot‐Garcher, Bahram Bodaghi, Salomon Y. Cohen, et al.
Journal Français d Ophtalmologie (2025) Vol. 48, Iss. 6, pp. 104536-104536
Closed Access
Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort
Bartłomiej Matejko, Tim van den Heuvel, Javier Castañeda, et al.
Diabetes Research and Clinical Practice (2024) Vol. 216, pp. 111832-111832
Open Access | Times Cited: 1
Bartłomiej Matejko, Tim van den Heuvel, Javier Castañeda, et al.
Diabetes Research and Clinical Practice (2024) Vol. 216, pp. 111832-111832
Open Access | Times Cited: 1
Can high-dose aflibercept satisfy unmet treatment needs in diabetic macular oedema?
Pierre‐Henry Gabrielle, Catherine Creuzot‐Garcher
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1111-1113
Closed Access
Pierre‐Henry Gabrielle, Catherine Creuzot‐Garcher
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1111-1113
Closed Access
Recent advances in ocular injectables for age-related macular degeneration, diabetic macular edema, and macular edema due to retinal vein occlusion
Meghana Kalavar, Jayanth Sridhar
Expert Review of Ophthalmology (2024) Vol. 20, Iss. 1, pp. 29-39
Closed Access
Meghana Kalavar, Jayanth Sridhar
Expert Review of Ophthalmology (2024) Vol. 20, Iss. 1, pp. 29-39
Closed Access
Dexamethasone implant for refractory macular edema secondary to diabetic retinopathy and retinal vein occlusion
Yuanyuan Zhong, Chong Tang, Lanyue Zhang, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 10, pp. 1837-1842
Closed Access
Yuanyuan Zhong, Chong Tang, Lanyue Zhang, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 10, pp. 1837-1842
Closed Access
